Simone Rota

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Local treatment of the primary tumour in mHSPC in the ARPI era: incremental value or overtreatment?

Local treatment of the primary tumour in mHSPC in the ARPI era: incremental value or overtreatment?

Journal: Expert review of anticancer therapy
Published: June 10, 2026

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

Journal: Familial cancer
Published: June 01, 2026

177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

Journal: Expert review of anticancer therapy
Published: May 06, 2026

Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targets.

Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targets.

Journal: ESMO open
Published: March 30, 2026

Impact of PSA Nadir on Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis.

Impact of PSA Nadir on Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis.

Journal: Targeted oncology
Published: March 30, 2026

An update on the treatment paradigm for non-clear cell renal cell carcinoma.

An update on the treatment paradigm for non-clear cell renal cell carcinoma.

Journal: Expert review of clinical pharmacology
Published: January 10, 2026

Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.

Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records.

Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025

When Effective Therapies Collide: Aorto-Esophageal Fistula After Thoracic Radiotherapy and Anti-VEGF TKI in a Long-Survivor with mRCC.

When Effective Therapies Collide: Aorto-Esophageal Fistula After Thoracic Radiotherapy and Anti-VEGF TKI in a Long-Survivor with mRCC.

Journal: Journal of kidney cancer and VHL
Published: November 23, 2025

Validation of a large language model as a decision tool for drug interaction in prostate cancer: A comparative study against UpToDate. Meet-URO 5/25 - GENIE study.

Validation of a large language model as a decision tool for drug interaction in prostate cancer: A comparative study against UpToDate. Meet-URO 5/25 - GENIE study.

Journal: Journal of geriatric oncology
Published: November 16, 2025

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models.

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models.

Journal: Communications medicine
Published: October 24, 2025

Triplet chemotherapy combined with anti Epidermal Growth Factor Receptor treatment in RAS wild-type colorectal cancer: a network metanalysis.

Triplet chemotherapy combined with anti Epidermal Growth Factor Receptor treatment in RAS wild-type colorectal cancer: a network metanalysis.

Journal: The oncologist
Published: October 12, 2025

Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer.

Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer.

Journal: European urology
Published: September 09, 2025
Showing 1-12 of 33

Last Updated: 09/26/2026